Dow Chemical DOW

Dow Inc. reports $11.27B revenue

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $11.27 billion for Q3 2026
  2. Net income: $458 million for Q3 2026
  3. Diluted EPS: $0.62 for Q3 2026
  4. Cash and equivalents: $4.14 billion as of Sep 30, 2026

Written from the 10-Q on EDGAR. Check the filing before you rely on it.

Get an email when Dow Chemical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

3 new legal mentions

Compared with the 10-Q for the period ended Jun 30, 2026.

New legal mentions (3)
  • The credit for income taxes for the three months ended September 30, 2025 was impacted by the recording of a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $ 100 million and a tax benefit of $ 20 million related to the sale of an additional portion of the… +1 more paragraph
  • The Company sought a refund of the withholding tax and, in the third quarter of 2026, the Company received the full refund from the CRA, equivalent to $ 318 million U.S. dollars.
  • The credit for income taxes in the third quarter of 2025 was impacted by the recording of a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $100 million and a tax benefit of $20 million related to the sale of an additional portion of the Company's membership… +1 more paragraph

Similar companies

Same SIC code (2821) and public float not reported.